Investing Profile

Charles Homcy

InvestorVC
Partner at Third Rock Ventures
thirdrockventures.com/people/...San Francisco, California
Photo of Charles Homcy, Partner at Third Rock Ventures
cb
$100K - $5.0M
$1.5M
7
$770M
CompanyStageDateRound SizeTotal Raised
Marea Therapeutics
Series AJun 2024$65M
Series BJun 2024$190M
$260M
Co-investors: Jeffrey Tong (Third Rock Ventures), Maha Katabi (Sofinnova Investments), Aaron Royston (venBio), Chris Garabedian (Perceptive Advisors)
Ambys Medicines
Series ADec 2021$47M
$110M
Co-investors: Jeffrey Tong (Third Rock Ventures)
Maze Therapeutics
Series AFeb 2019$190M
$500M
Co-investors: Jonathan Lim (SignalFire), Jonathan Lim (ARCH Venture Partners), Andy Tran (Matrix Capital Management Company), James W. Brush (Frazier Healthcare Partners)
CytomX Therapeutics
Series CJan 2015$20M
$61M
Co-investors: Tim Shannon (Canaan Partners), Neil Exter (Third Rock Ventures)
MyoKardia
Series UnknownAug 2014$10M
$10M
Topica Pharmaceuticals
Series BOct 2011$27M
$27M